Yang Y - Search Results

1

Novel molecular insights into pyroptosis in triple-negative breast cancer prognosis and immunotherapy.

Yu B, Luo J, Yang Y, Zhen K, Shen B. Yu B, et al. Among authors: yang y. J Gene Med. 2024 Jan;26(1):e3645. doi: 10.1002/jgm.3645. Epub 2023 Dec 2. J Gene Med. 2024. PMID: 38041540

2

Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.

Yang Y, Zhu Y, Li X, Zhang X, Yu B. Yang Y, et al. Arch Gynecol Obstet. 2021 Jun;303(6):1599-1606. doi: 10.1007/s00404-021-06015-9. Epub 2021 Mar 31. Arch Gynecol Obstet. 2021. PMID: 33791842

3

Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction.

Yang YF, Yu B, Zhang XX, Zhu YH. Yang YF, et al. Medicine (Baltimore). 2021 Apr 23;100(16):e25541. doi: 10.1097/MD.0000000000025541. Medicine (Baltimore). 2021. PMID: 33879700 Free PMC article.

4

Hsa_circ_0001925 promotes malignant progression in triple-negative breast cancer via miR-1299/YY1 axis.

Shen BJ, Yang YF, Zhang XX. Shen BJ, et al. Thorac Cancer. 2023 Mar;14(8):746-757. doi: 10.1111/1759-7714.14803. Epub 2023 Feb 8. Thorac Cancer. 2023. PMID: 36754085 Free PMC article.

5

Integrated Bioinformatics Analysis to Identify a Novel Four-Gene Prognostic Model of Breast Cancer and Reveal Its Association with Immune Infiltration.

Zhu Y, Luo J, Yang Y. Zhu Y, et al. Among authors: yang y. Crit Rev Immunol. 2024;44(2):1-14. doi: 10.1615/CritRevImmunol.2023050829. Crit Rev Immunol. 2024. PMID: 38305332

6

Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing.

Zheng K, Zhang XX, Yu X, Yu B, Yang YF. Zheng K, et al. Medicine (Baltimore). 2024 May 10;103(19):e38144. doi: 10.1097/MD.0000000000038144. Medicine (Baltimore). 2024. PMID: 38728457 Free PMC article.

7

Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1.

Ma W, Zhang L, Chen W, Chang Z, Tu J, Qin Y, Yao Y, Dong M, Ding J, Li S, Li F, Deng Q, Yang Y, Feng T, Zhang F, Shao X, He X, Zhang L, Hu G, Liu Q, Jiang YZ, Zhu S, Xiao Z, Su D, Liu T, Liu S. Ma W, et al. Among authors: yang y. Protein Cell. 2024 May 28;15(6):419-440. doi: 10.1093/procel/pwae005. Protein Cell. 2024. PMID: 38437016 Free PMC article.

8

Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and Wnt signaling pathways in lung cancer.

Wang Y, He B, Dong Y, He GJ, Qi XW, Li Y, Yang YF, Rao Y, Cen ZS, Han F, Ding J, Li JJ. Wang Y, et al. Among authors: yang yf. Cancer Biomark. 2021;31(3):239-254. doi: 10.3233/CBM-200540. Cancer Biomark. 2021. PMID: 33896818

9

Combining interferon-γ release assays and metagenomic next-generation sequencing for diagnosis of pulmonary tuberculosis: a retrospective study.

Liu Y, Fang M, Yuan C, Yang Y, Yu L, Li Y, Hu L, Li J. Liu Y, et al. Among authors: yang y. BMC Infect Dis. 2024 Nov 18;24(1):1316. doi: 10.1186/s12879-024-10206-5. BMC Infect Dis. 2024. PMID: 39558256

10

Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer.

Yang Y, Badura ML, O'Leary PC, Delavan HM, Robinson TM, Egusa EA, Zhong X, Swinderman JT, Li H, Zhang M, Kim M, Ashworth A, Feng FY, Chou J, Yang L. Yang Y, et al. Nat Cancer. 2024 Nov 18. doi: 10.1038/s43018-024-00848-4. Online ahead of print. Nat Cancer. 2024. PMID: 39558146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108,238 results

Search Page

Filters